PureCycle Technologies Second Quarter 2025 Corporate Update
PureCycle Technologies (Nasdaq: PCT) provided a Q2 2025 corporate update highlighting significant operational and commercial progress. The company successfully raised $300 million through Series B convertible preferred stock in June and plans expansion in Thailand and Belgium. The company's Gen 2 Purification design aims for 300 million pounds yearly capacity, targeting one billion pounds installed capacity across US, Europe, and Asia by 2030.
Operationally, PCT produced 3.4 million pounds of resin in Q2 and achieved a rate test of 14,000 pounds per hour. The company recognized revenue of $1.7 million and is adding compounding operations at Ironton facility, expected to eliminate $4 million in annual third-party costs. Commercially, PCT advanced trials in packaging, film, and textile applications, securing a 5-million-pound supply agreement with Emerald Carpets and progressing through P&G's qualification process.
PureCycle Technologies (Nasdaq: PCT) ha fornito un aggiornamento aziendale per il secondo trimestre 2025, evidenziando importanti progressi operativi e commerciali. La società ha raccolto con successo 300 milioni di dollari tramite azioni privilegiate convertibili di Serie B a giugno e prevede un'espansione in Thailandia e Belgio. Il progetto di purificazione Gen 2 punta a una capacità annua di 300 milioni di libbre, con l'obiettivo di raggiungere un miliardo di libbre di capacità installata tra Stati Uniti, Europa e Asia entro il 2030.
Dal punto di vista operativo, PCT ha prodotto 3,4 milioni di libbre di resina nel secondo trimestre e ha raggiunto una velocità di produzione di 14.000 libbre all'ora. L'azienda ha registrato ricavi per 1,7 milioni di dollari e sta implementando operazioni di compounding presso l'impianto di Ironton, che si prevede elimineranno 4 milioni di dollari di costi annuali verso terzi. Sul fronte commerciale, PCT ha fatto progressi nelle prove per applicazioni nel packaging, film e tessuti, assicurandosi un contratto di fornitura da 5 milioni di libbre con Emerald Carpets e avanzando nel processo di qualificazione di P&G.
PureCycle Technologies (Nasdaq: PCT) presentó una actualización corporativa del segundo trimestre de 2025 destacando avances significativos en operaciones y comercio. La empresa recaudó exitosamente 300 millones de dólares mediante acciones preferentes convertibles Serie B en junio y planea expandirse en Tailandia y Bélgica. El diseño de purificación Gen 2 apunta a una capacidad anual de 300 millones de libras, con la meta de alcanzar una capacidad instalada de mil millones de libras en EE.UU., Europa y Asia para 2030.
Operativamente, PCT produjo 3.4 millones de libras de resina en el segundo trimestre y logró una tasa de prueba de 14,000 libras por hora. La empresa reconoció ingresos de 1.7 millones de dólares y está incorporando operaciones de compounding en su planta de Ironton, lo que se espera elimine 4 millones de dólares en costos anuales a terceros. Comercialmente, PCT avanzó en ensayos para aplicaciones en empaques, películas y textiles, asegurando un acuerdo de suministro por 5 millones de libras con Emerald Carpets y progresando en el proceso de calificación de P&G.
PureCycle Technologies (나스닥: PCT)는 2025년 2분기 기업 업데이트를 통해 중요한 운영 및 상업적 진전을 발표했습니다. 회사는 6월에 시리즈 B 전환 우선주를 통해 3억 달러를 성공적으로 조달했으며 태국과 벨기에에서의 확장을 계획 중입니다. Gen 2 정제 설계는 연간 3억 파운드 생산 능력을 목표로 하며, 2030년까지 미국, 유럽, 아시아 전역에서 10억 파운드 설치 용량을 달성하는 것을 목표로 합니다.
운영 측면에서 PCT는 2분기에 340만 파운드의 수지를 생산했으며 시간당 14,000파운드의 생산 속도를 기록했습니다. 회사는
PureCycle Technologies (Nasdaq : PCT) a publié une mise à jour d'entreprise pour le deuxième trimestre 2025, mettant en avant des progrès significatifs tant opérationnels que commerciaux. La société a levé avec succès 300 millions de dollars via des actions privilégiées convertibles de série B en juin et prévoit une expansion en Thaïlande et en Belgique. Le design de purification Gen 2 vise une capacité annuelle de 300 millions de livres, avec pour objectif un milliard de livres de capacité installée aux États-Unis, en Europe et en Asie d'ici 2030.
Sur le plan opérationnel, PCT a produit 3,4 millions de livres de résine au deuxième trimestre et atteint un débit de test de 14 000 livres par heure. La société a enregistré un chiffre d'affaires de 1,7 million de dollars et ajoute des opérations de compoundage dans son site d'Ironton, ce qui devrait permettre d'éliminer 4 millions de dollars de coûts annuels auprès de tiers. Sur le plan commercial, PCT a progressé dans les essais pour les applications d'emballage, film et textile, sécurisant un contrat d'approvisionnement de 5 millions de livres avec Emerald Carpets et avançant dans le processus de qualification de P&G.
PureCycle Technologies (Nasdaq: PCT) gab ein Unternehmensupdate für das zweite Quartal 2025 bekannt, das bedeutende operative und kommerzielle Fortschritte hervorhob. Das Unternehmen hat im Juni erfolgreich 300 Millionen US-Dollar durch Series-B wandelbare Vorzugsaktien aufgenommen und plant eine Expansion in Thailand und Belgien. Das Gen-2-Reinigungsdesign zielt auf eine jährliche Kapazität von 300 Millionen Pfund ab, mit dem Ziel, bis 2030 eine installierte Kapazität von einer Milliarde Pfund in den USA, Europa und Asien zu erreichen.
Operativ produzierte PCT im zweiten Quartal 3,4 Millionen Pfund Harz und erreichte eine Testgeschwindigkeit von 14.000 Pfund pro Stunde. Das Unternehmen erzielte Einnahmen von 1,7 Millionen US-Dollar und baut Kompoundierungsprozesse in der Anlage in Ironton aus, was voraussichtlich jährliche Drittanbieterkosten von 4 Millionen US-Dollar einsparen wird. Kommerziell hat PCT Fortschritte bei Versuchen in den Bereichen Verpackungen, Folien und Textilien gemacht, einen Liefervertrag über 5 Millionen Pfund mit Emerald Carpets abgeschlossen und macht Fortschritte im Qualifizierungsprozess von P&G.
- Successful $300 million capital raise through Series B convertible preferred stock
- Production capacity reached 14,000 pounds per hour at Ironton Facility
- New compounding operations will save $4 million in annual costs
- Secured 5-million-pound supply agreement with Emerald Carpets
- In negotiations for more than 15 applications with various converters
- Planned expansion to reach 1 billion pounds capacity across three continents by 2030
- Limited Q2 2025 revenue of only $1.7 million
- Still in qualification process with major partner P&G
- Significant capital requirements for planned global expansion
- Operating as a going concern remains a risk factor
Insights
PureCycle's Q2 shows promising commercial traction and global expansion plans following $300M capital raise, despite modest current revenues.
PureCycle's Q2 update reveals significant operational momentum following their
The commercial pipeline shows promising development with over 15 applications now in post-trial negotiations. Their commercial partnership with Emerald Carpets for 5 million pounds of PureFive™ resin over the next year represents their first significant offtake agreement. Additionally, progress with film applications and successful trials with major industry partners like Brückner Maschinenbau signal expanding market opportunities.
The planned integration of compounding operations at the Ironton facility is a strategic move expected to eliminate approximately
While current revenue remains modest, PureCycle is following the typical cleantech commercialization curve - building infrastructure and market validation before revenue acceleration. Their qualification progress with Procter & Gamble, scheduled for production implementation by year-end, could serve as a major commercial catalyst given P&G's market influence. The company appears to be transitioning from technology validation to commercial scale-up, though investors should monitor whether production increases translate to corresponding revenue growth in upcoming quarters.
ORLANDO, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- PureCycle Technologies, Inc. (Nasdaq: PCT), a U.S.-based company revolutionizing plastic recycling, announced today a corporate update for the second quarter ending June 30, 2025.
Management Commentary
PureCycle CEO Dustin Olson commented, “We have begun to implement our growth plans following our successful
Olson continued, “On the commercial front, we continue to make progress with trials in the packaging, film and textile spaces for both food and non-food applications. Our team is now in negotiations with several companies and working through the process to bring these opportunities to commercialization. We continue to see interest in our PureFive™ resin and are still confident we will achieve increased sales in the second half of 2025 that should position us well for 2026.”
Commercial Update
PureCycle’s compounding and trial successes continued during the second quarter of 2025. Through the Company’s various customer interactions, PureCycle is developing a wide-ranging portfolio of PureFive Choice™ resin grades. This includes one-pellet solutions for food-grade film, injection molded and thermoformed applications.
PureCycle has delivered these PureFive Choice™ resin grades to various converters for trials. The resin has been successfully molded into storage totes, coffee lids, dairy containers, pens and a variety of other polypropylene packaging applications. PureCycle is now in post-trial negotiations for more than 15 applications with numerous converters or brand owners.
The Company previously announced a partnership with Emerald Carpets to drive circularity in the trade show industry. Emerald signed its commercial supply agreement for approximately 5 million pounds of PureFive™ resin over the next 12 months. The PureFive Choice™ resin will be blended into Emerald Carpets’ existing fiber production and allow for trade shows around the world to use carpets made with recycled content.
PureCycle also made progress on the use of PureFive™ resin in biaxially-oriented polypropylene (BOPP) film. The PureFive Choice™ resin grade for film passed an industrial trial for a leading provider of tapes and films. Work has also continued with Germany-based Brückner Maschinenbau GmbH, the world’s leading supplier of production lines for manufacturing a wide range of stretched films. A larger-scale trial with Brückner is scheduled for later this month and, if successful, should provide PureCycle with thousands of meters worth of samples to share with brand owners. BOPP film has a wide range of end-use applications, including food packaging for snacks, candy and baked goods.
PureCycle has continued to advance through the extensive qualification process with Procter & Gamble (P&G) for a variety of applications. Scaled production tests of the spout and dose caps for select bottles of P&G products are scheduled for September. Products with PureFive™ resin are planned to be in production by the end of 2025 and in stores in early 2026.
Operations Update
PureCycle produced 3.4 million pounds of resin in the second quarter of 2025. The Company took a short, planned outage in early June to update and improve certain areas of the Ironton Facility. The plant returned to operations on June 9, and the facility has been running consistently since then. PureCycle continues to assess the upper limits of the Ironton Facility and successfully completed a rate test at 14,000 pounds per hour on August 1.
To meet expected demand and better streamline its processes, PureCycle will add compounding operations to the Ironton, Ohio purification facility. The Company has begun efforts to install a new twin-screw extruder with multiple feeders to bring approximately 100 million pounds of annual compounding capacity to the site. This will enable the blending of specific resins for key customer applications, including film, thermoforming and thin-wall injection molding applications. The move is expected to eliminate approximately
PureCycle Financial Update
During the second quarter of 2025, PureCycle recognized revenue of approximately
In the second quarter of 2025, PureCycle sold a total of
In June 2025, PureCycle raised
About PureCycle Technologies
PureCycle Technologies LLC. (“PCT”), a subsidiary of PureCycle Technologies, Inc., holds a global license for the only patented dissolution recycling technology, developed by The Procter & Gamble Company (P&G), that is designed to transform polypropylene plastic waste (designated as #5 plastic) into a continuously renewable resource. The unique purification process removes color, odor, and other impurities from #5 plastic waste resulting in our PureFive™ resin that can be recycled and reused multiple times, changing our relationship with plastic. www.purecycle.com
Forward-Looking Statements
This press release contains forward-looking statements, including statements about the continued execution of PureCycle’s business plan, the expected results of tests and trials, the expected timing of commercial sales, and planned future updates. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Forward-looking statements generally relate to future events or PureCycle’s future financial or operating performance and may refer to projections and forecasts. Forward-looking statements are often identified by future or conditional words such as “plan,” “believe,” “expect,” “anticipate,” “intend,” “outlook,” “estimate,” “forecast,” “project,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict,” “should,” “would” and other similar words and expressions (or the negative versions of such words or expressions), but the absence of these words does not mean that a statement is not forward-looking.
The forward-looking statements are based on the current expectations of PureCycle’s management and are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of this press release. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in the section entitled “Risk Factors” in each of PureCycle’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and PureCycle’s Quarterly Reports on Form 10-Q for various quarterly periods, those discussed and identified in other public filings made with the Securities and Exchange Commission by PureCycle and the following: PCT's ability to obtain funding for its operations and future growth and to continue as a going concern; PCT's ability to meet, and to continue to meet, applicable regulatory requirements for the use of PCT’s PureFive™ resin in food grade applications (including in the United States, Europe, Asia and other future international locations); PCT's ability to comply on an ongoing basis with the numerous regulatory requirements applicable to the PureFive™ resin and PCT’s facilities (including in the United States, Europe, Asia and other future international locations); expectations and changes regarding PCT’s strategies and future financial performance, including its future business plans, expansion plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures, and PCT’s ability to invest in growth initiatives, which could be impacted by significant changes to tariffs on foreign imports; the ability of PCT’s first commercial-scale recycling facility in Lawrence County, Ohio, the Ironton Facility, to be appropriately certified by Leidos, following certain performance and other tests, and commence full-scale commercial operations in a timely and cost-effective manner, or at all; PCT’s ability to meet, and to continue to meet, the requirements imposed upon it and its subsidiaries by the funding for its operations, including the funding for the Ironton Facility; PCT’s ability to minimize or eliminate the many hazards and operational risks at its manufacturing facilities that can result in potential injury to individuals, disrupt its business (including interruptions or disruptions in operations at its facilities), and subject PCT to liability and increased costs; PCT’s ability to complete the necessary funding with respect to, and complete the construction of its new polypropylene recycling facility in Thailand, its first commercial-scale European plant located in Antwerp, Belgium, and the multi-line purification facility to be built in Augusta, Georgia in a timely and cost-effective manner; PCT's ability to execute its growth plan to bring an additional one billion pounds of installed polypropylene recycling capability online before 2030, including its ability to meet related construction, regulatory, and financing requirements; PCT’s ability to procure, sort and process polypropylene plastic waste at its planned plastic waste prep facilities; PCT’s ability to maintain exclusivity under The Procter & Gamble Company license; the implementation, market acceptance and success of PCT’s business model and growth strategy; the success or profitability of PCT’s offtake arrangements; the potential impact of economic, business, and/or competitive factors, including interest rates, availability of capital, economic cycles, and other macro-economic impacts (such as tariffs); changes in the prices and availability of materials (such as steel and other materials needed for the construction of future PreP and purification facilities), including those changes caused by inflation, tariffs and supply chain conditions, such as increased transportation costs, and our ability to obtain such materials in a timely and cost-effective manner; the ability to source feedstock with a high polypropylene content at a reasonable cost; PCT’s future capital requirements and sources and uses of cash; developments and projections relating to PCT’s competitors and industry; the outcome of any legal or regulatory proceedings to which PCT is, or may become, a party including the securities class action and putative class action cases; geopolitical risk and changes in applicable laws or regulations; the possibility that PCT may be adversely affected by other economic, business, and/or competitive factors, including interest rates, availability of capital, economic cycles, and other macro-economic impacts; turnover in employees and increases in employee-related costs; changes in the prices and availability of labor (including labor shortages); any business disruptions due to political or economic instability, pandemics, armed hostilities (including the ongoing conflict between Russia and Ukraine and the conflict in the Middle East); the potential impact of climate change on PCT, including physical and transition risks, higher regulatory and compliance costs, reputational risks, and availability of capital on attractive terms; and operational risk.
PCT undertakes no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.
Should one or more of these risks or uncertainties materialize or should any of the assumptions made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events.
PureCycle Contact Christian Bruey cbruey@purecycle.com Investor Relations Contact Eric DeNatale edenatale@purecycle.com
FAQ
What was PureCycle Technologies (PCT) revenue in Q2 2025?
How much capital did PCT raise in June 2025?
What is PureCycle's production capacity target by 2030?
How many pounds of resin did PCT produce in Q2 2025?
What is the status of PCT's partnership with Procter & Gamble?
What major commercial agreement did PCT secure in Q2 2025?
